HEMODYNAMICS AND CARDIAC CONTRACTILE FUNCTION IN TYPE 1 DIABETES
https://doi.org/10.18087/cardio.2022.8.n1967
Abstract
The cardiohemodynamics was studied 1 week after the administration of streptozotocin (60 mg / kg) or 2 weeks after a dose of 30 mg / kg. All rats had a significantly elevated level of glucose in the blood (up to 27—31 mM). In an echocardiographic study, about 1/3 of diabetic animals exhibited systolic dysfunction, and the remaining 2/3 — diastolic dysfunction with an increase in isovolumic relaxation time by 1.5 times. The catheterization of the left ventricle (LV) with a sensor that allows simultaneous measuring LV pressure and volume in both groups revealed decreased cardiac output by 25—31% and maximal ejection rate by 34—50%. However, LV developed pressure, the maximal rate of its development and the level of blood pressure remained within the control values, thus reduced LV ejection rate was probably due to increased arterial stiffness — a negative correlation was found between these indicators (r = - 0.70). The diastolic dysfunction group differed from systolic dysfunction by a significantly smaller end diastolic volume by 22%. Thus, in type 1 diabetes, LV remodeling with reduced end diastolic volume allows to maintain a normal ejection fraction in the presence of distinct heart failure.
About the Authors
V. L. LakomkinRussian Federation
Leading researcher in experimental heart pathology lab, Ph. D in Institute of Experimental cardiology named after academician V.N. Smirnov
A. A. Abramov
Russian Federation
Researcher in experimental heart pathology lab, Ph. D in Institute of Experimental cardiology named after academician V.N. Smirnov
E. V. Lukoshkova
Russian Federation
Leading researcher in experimental heart pathology lab, Ph. D. MD. in Institute of Experimental cardiology named after academician V.N. Smirnov
A. V. Prosvirnin
Russian Federation
Physician in department of ultrasound investigation methods, in Institute of Clinical Cardiology named after academician A.L. Miyasnikov
V. I. Kapelko
Russian Federation
Leading researcher in experimental heart pathology lab, Ph. D, MD, professor, in Institute of Experimental cardiology named after academician V.N. Smirnov
References
1. Litwin SE, Raya TE, Anderson PG, Daugherty S, Goldman S. Abnormal cardiac function in the streptozotocin-diabetic rat. Changes in active and passive properties of the left ventricle. J Clin Invest. 1990; 86(2):481-488.
2. doi: 10.1172/JCI114734.
3. An D, Rodrigues B. Role of changes in cardiac metabolism in development of diabetic cardiomyopathy. Am J Physiol Heart Circ Physiol. 2006; 291(4): H1489–H1506, First published June 2, 2006; doi:10.1152/ajpheart.00278.2006.
4. Borges GR, de Oliveira M, Salgado HC, Fazan R Jr. Myocardial performance in conscious streptozotocin diabetic rats. Cardiovascular Diabetology. 2006; 5(26). PMID: 17144912 doi: 10.1186/1475-2840-5-26
5. Cosson S., Kevorkian J.P. Left ventricular diastolic dysfunction: an early sign of diabetic cardiomyopathy? Diabetes Metab. 2003; 29(5): 455-466.
6. doi: 10.1016/s1262-3636(07)70059-9
7. Dillmann W.H. Diabetic cardiomyopathy: what is it and can it Be fixed? Circ. Res. 2019; 124(8):1160-1162. doi: 10.1161/CIRCRESAHA.118.314665
8. Abramov AA, Lakomkin VL, Prosvirnin AV, Kapelko VI. Characteristics of left ventricular pressure and volume at diastolic and systolic dysfunction. Kardiologiya 2019; 59(4): 45-51 (In Russ.). DOI:10.18087/cardio.2019.4.2647
9. Ceriello A, Quagliaro L, D'Amico M, Di Filippo C, Marfella R, Nappo F, Berrino L, Rossi F, Giugliano D. Acute hyperglycemia induces nitrotyrosine formation and apoptosis in perfused heart from rat . Diabetes. 2002; 51(4): 1076-82. PMID: 11916928, DOI: 10.2337/diabetes.51.4.1076
10. Shen Xia, Karin E Bornfeldt. Mouse models for studies of cardiovascular complications of type 1 diabetes. Ann N Y Acad Sci 2007; Apr; (1103):202-17. doi: 10.1196/annals.1394.004. Epub 2007 Mar 21. PMID: 17376839
11. G. S. Boleeva, S. M. Mochalov, O. S. Tarasova Functional Alterations of Arterial Vessels in Experimental Models of Type 1 Diabete Mellitus. SUCCESSES OF PHYSIOLOGICAL SCIENCES, 2014; 45(2): 20—36. (In Russ.) ISSN: 0301-1798
12. Schnell O, Cappuccio F, Genovese S, Standl E, Valensi P, Ceriello A. Type 1 diabetes and cardiovascular disease. Cardiovasc Diabetol. 2013; 28(12): 156. PMID: 24165454 PMCID: PMC3816572
13. DOI: 10.1186/1475-2840-12-156
14. Shivu GN, Phan TT, Abozguia K, Ahmed I, Wagenmakers A, Henning A, Narendran P, Stevens M, Frenneaux M. Relationship between coronary microvascular dysfunction and cardiac energetics impairment in type 1 diabetes mellitus Circulation 2010; Mar 16; 121(10):1209-15.
15. doi: 10.1161/CIRCULATIONAHA.109.873273.
16. V.I. Kapelko, V.L. Lakomkin, E.V. Lukoshkova, V.V. Gramovich, O.N. Vyborov, A.A. Abramov, N.A. Undrovinas, V.V. Ermishkin, S.V. Lakomkin, S.P. Veselova, V.S. Zhdanov, V.P. Shirinsky. Complex Study of the Rat Heart at Isoproterenol Damage Kardiologiya 2014; 54(3):46-56. (In Russ.) ISSN: 0022-9040
17. LAKOMKIN V.L., ABRAMOV A.A. LUKOSHKOVA E.V.PROSVIRNIN A.V., KAPELKO V.I. PREVENTION OF DIASTOLIC DYSFUNCTION CAUSED BY DOXORUBICIN BY MITOCHONDRIAL ANTIOXIDANT PLASTOMITIN. Kardiologiya 2020; 60(7): 40-44. (In Russ.). DOI:10.18087/cardio.2020.7.n1157
18. Lakomkin V.L., Abramov A.A., Studneva I.M., Ulanova A.D., Vikhlyantsev I.M., Prosvirnin A.V., Lukoshkova E.V., Kapelko V.I. Early changes of energy metabolism, isomorphic content and level of titin phosphorylation at diastolic dysfunction Kardiologiia, 2020;60(2):4-9. (In Russ.) DOI: http://dx.doi.org/10.18087/cardio.2020.3.n531
Review
For citations:
Lakomkin V.L., Abramov A.A., Lukoshkova E.V., Prosvirnin A.V., Kapelko V.I. HEMODYNAMICS AND CARDIAC CONTRACTILE FUNCTION IN TYPE 1 DIABETES. Kardiologiia. 2022;62(8):33-37. https://doi.org/10.18087/cardio.2022.8.n1967